Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-02-20
1993-08-24
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514253, 514307, 544215, 544333, 544405, 546145, 546146, 546147, A61K 3147, A61K 31495, A61K 31505, A61K 3153
Patent
active
052389359
ABSTRACT:
N-acyltetrahydroisoquinolines including novel compounds of the formula ##STR1## wherein R.sup.1 is a C10-C25 alkyl chain; a substituted C10-C25 alkyl chain; an interrupted C10-C25 alkyl chain; a substituted interrupted C10-C25 alkyl chain; diphenylamino; di-(R.sup.2 -substituted phenyl)amino; di-(heteroaryl)amino; di-(R.sup.2 -substituted heteroaryl)amino; diphenylmethyl; or di-(R.sup.2 -substituted phenyl)methyl;
REFERENCES:
patent: 4460775 (1984-07-01), Portlock
patent: 4514569 (1985-04-01), Hendrickson et al.
patent: 4555503 (1985-11-01), Patchett
patent: 4634715 (1987-01-01), Greenlee et al.
patent: 4729985 (1988-03-01), Kleinman et al.
patent: 4743450 (1988-05-01), Harris et al.
patent: 4882339 (1989-11-01), Wasley
patent: 4904300 (1990-02-01), Schneider et al.
Stenlake, et al., Eur. J. Med. Chem.-Chim. Ther., 9(3), 239-242 (1974); Chem. Abstr. 82(9): 57976v.
Dugar Sundeep
Kogan Timothy
Ivy C. Warren
Magatti Anita W.
Schering Corporation
Thompson Paul A.
Turnipseed James H.
LandOfFree
N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme A: does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme A:, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme A: will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-829420